If You Invested $100 In This Stock 10 Years Ago, You Would Have $2,800 Today
Abiomed (NASDAQ:ABMD) has outperformed the market over the past 10 years by 29.45% on an annualized basis producing…
Analyst Forecasts $101-117/Share Offer Price For Horizon Therapeutics’ Buyout
Horizon Therapeutics Plc (NASDAQ:HZNP) confirmed it’s engaged in preliminary talks with Amgen Inc (NASDAQ:AMGN), Janssen Global Service, and Sanofi SA SNY on potential takeover offers for…
Here’s How Much You Would Have Made Owning Abiomed Stock In The Last 15 Years
Abiomed (NASDAQ:ABMD) has outperformed the market over the past 15 years by 18.87% on an annualized basis producing…
Here’s How Much $100 Invested In Abiomed 20 Years Ago Would Be Worth Today
Abiomed (NASDAQ:ABMD) has outperformed the market over the past 20 years by 18.13% on an annualized basis producing an average annual return of 25.63%. Currently, Abiomed has a market capitalization of $16.86 billion.
Deutsche Bank Downgrades Abiomed to Hold, Raises Price Target to $388
Deutsche Bank analyst Pito Chickering downgrades Abiomed (NASDAQ:ABMD) from Buy to Hold and raises the price target from $355 to $388.
Gartner, Sony, Uber And Other Big Gainers From Tuesday
U.S. stocks closed lower on Tuesday, with the Nasdaq Composite dropping around 100 points. Here is the list of some big stocks recording gains in the previous session.
Nasdaq Down 60 Points; Eli Lilly Lowers Earnings Forecast
U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping around 50 points on Tuesday.
Dow Drops Over 200 Points; Crude Oil Rises Sharply
U.S. stocks traded lower midway through trading, with the Dow Jones dropping more than 200 points on Tuesday.